PH284 increased feelings of hunger and was safe in patients with cancer cachexia, which results in significant weight loss.

Findings from an exploratory 2a study showed improvements in patients with cancer cachexia with PH284 compared with placebo.

Vistagen has reported positive outcomes from the exploratory Phase IIA trial of an investigational pherine nasal spray, PH284 ...

Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced positive results from an exploratory Phase 2A study ...

Vistagen (VTGN) announced results from an exploratory Phase 2A study of PH284 in cancer cachexia. PH284 is an investigational pherine nasal ...

Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report)’s share price traded up 8.1% during trading on Thursday . The company traded as high as $0.76 and last traded at $0.76. 4,300 shares ...

Vistagen reports positive results from exploratory phase 2A study of PH284 in cancer cachexia: South San Francisco, California Thursday, January 16, 2025, 16:00 Hrs [IST] Vistagen ...

Nasal Irrigation The nasal irrigation market is expanding as more people seek effective solutions for sinus issues and respiratory health. WILMINGTON, DE, UNITED STATES, December 21, 2024 /EINPresswir ...

Contemporary Pediatrics' editorial advisory member Russell Libby, MD, FAAP, highlights 2024 FDA approval of epinephrine nasal spray (Neffy) in this video interview.

Oakland County officials credit the decline to the availability of Narcan training and a public health, sheriff's office partnership ...

"This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat population and offers hope for the millions of people affected by TRD," he added. Analysts at ...